Sign up to the UK Share Picking Game

Oxford Biomedica (OXB) Share Price

Health Care Sector


Members only

To view this content and much more please Sign Up


NOTE: This is based on 122 open tips for Oxford Biomedica (OXB)


Oxford Biomedica (OXB)
Latest Quote Price

Oxford Biomedica (OXB)
Price Change (%)


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000


Oxford Biomedica (OXB) Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Oxford Biomedica (OXB) Latest Tips

Type Tipster SectorScore Start date Performance
Liberum Capital 2023-09-26 16:30:00 26/09/2023
JP Morgan 2023-09-22 04:58:00 22/09/2023
Liberum Capital 2023-09-04 08:19:00 04/09/2023
Numis 2023-06-29 09:44:00 29/06/2023
JP Morgan 2023-06-21 05:00:00 21/06/2023

Oxford Biomedica (OXB) Data Charts

Premium Charts

Oxford Biomedica (OXB) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : Latest Ask :
High Today : Low Today :
This Years High : This Years Low :
Volume : MKT Cap :

Oxford Biomedica Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Oxford Biomedica Tips

Type Tipster SectorScore Start date Performance
Liberum Capital 2023-09-26 16:30:00 26/09/2023
JP Morgan 2023-09-22 04:58:00 22/09/2023
Liberum Capital 2023-09-04 08:19:00 04/09/2023
Numis 2023-06-29 09:44:00 29/06/2023
JP Morgan 2023-06-21 05:00:00 21/06/2023

Stock Splits and Consolidations

30/05/2018 – Stock Consolidation 50.000:1.000